TCWM
DCPH

Total Clarity Wealth Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Total Clarity Wealth Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-90
Closed -$4K – 790
2021
Q1 		$4K Buy
+90
New +$4.19K ﹤0.01% 741

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Total Clarity Wealth Management's DCPH Position: Q2 2021 in Review

Total Clarity Wealth Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 90 shares — an estimated $4K sold.

Total Clarity Wealth Management first reported a position in DCPH in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • Total Clarity Wealth Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 90 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $4K.
  • Total Clarity Wealth Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Total Clarity Wealth Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Total Clarity Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.